In fact, the researchers rather observed an opposite trend, but not statistically significant, they point out: among the subjects who took vitamin E, the number of cases of prostate cancer was slightly higher. And those who took selenium would have been slightly more likely to suffer from type 2 diabetes. Although these data could be a coincidence, since the difference between the groups did not reach a significant level, the authorities of the NCI preferred. stop treatment. The subjects will be followed for three years, as a precautionary measure.

However, the data collected to date as part of this clinical trial leads to the conclusion that these supplements do not have a significant protective effect against prostate cancer. This study, Selenium and Vitamin E Cancer Prevention Trial (SELECT), was started in 2001 after the results of other trials established a link between vitamin E and selenium and the prevention of prostate cancer.

The study was taking place simultaneously in the United States, Puerto Rico and Canada. The participants were divided into four groups of more than 8 subjects each: one took vitamin E and selenium, another group took vitamin E and a placebo, a third took selenium and a placebo, while the last group took vitamin E and a placebo. group received two placebos.

The Canadian Cancer Society estimates that 24 men will be diagnosed with prostate cancer in 700 and 2008 will die from it.

Pierre Lefrançois – PasseportSanté.net

According to CNN, AP et Radio Canada.

1. NCI Office of Media Relations. Review of Prostate Cancer Prevention Study Shows No Benefit for Use of Selenium and Vitamin E Supplements. NIH News, October 27, 2008 press release, United States. [Accessed October 31, 2008]. www.nih.gov/news/health/oct2008